[go: up one dir, main page]

BRPI0605902A - processo de purificação para intermediário de anastrozol - Google Patents

processo de purificação para intermediário de anastrozol

Info

Publication number
BRPI0605902A
BRPI0605902A BRPI0605902-3A BRPI0605902A BRPI0605902A BR PI0605902 A BRPI0605902 A BR PI0605902A BR PI0605902 A BRPI0605902 A BR PI0605902A BR PI0605902 A BRPI0605902 A BR PI0605902A
Authority
BR
Brazil
Prior art keywords
anastrozole
processes
purification process
anastrozol
anastrozole intermediate
Prior art date
Application number
BRPI0605902-3A
Other languages
English (en)
Inventor
Alessandro Pontiroli
Roberto Casalone
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of BRPI0605902A publication Critical patent/BRPI0605902A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/33—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/172307—Cyanide or isocyanide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCESSO DE PURIFICAçãO PARA INTERMEDIáRIO DE ANASTROZOL. A invenção é dirigida a processos para purificação de intermediário de Anastrozol, 3,5-bis(2-cianoisopropil)tolueno, processos para produção de Anastrozol, processos para preparação de Anastrozol e composições farmacêuticas de Anastrozol preparadas por meio dos processos da invenção.
BRPI0605902-3A 2005-06-27 2006-06-27 processo de purificação para intermediário de anastrozol BRPI0605902A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69452805P 2005-06-27 2005-06-27
PCT/US2006/025095 WO2007002722A2 (en) 2005-06-27 2006-06-27 Synthesis of anastrozole and purification of one of its intermediate

Publications (1)

Publication Number Publication Date
BRPI0605902A true BRPI0605902A (pt) 2007-12-18

Family

ID=36969179

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0611116-5A BRPI0611116A2 (pt) 2005-06-27 2006-06-27 uma impureza de intermediário de anastrozol e seus usos
BRPI0605902-3A BRPI0605902A (pt) 2005-06-27 2006-06-27 processo de purificação para intermediário de anastrozol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0611116-5A BRPI0611116A2 (pt) 2005-06-27 2006-06-27 uma impureza de intermediário de anastrozol e seus usos

Country Status (9)

Country Link
US (2) US20070087441A1 (pt)
EP (1) EP1896429A2 (pt)
JP (2) JP2008511684A (pt)
KR (2) KR20080015436A (pt)
CN (2) CN101208312A (pt)
BR (2) BRPI0611116A2 (pt)
CA (1) CA2606958A1 (pt)
MX (1) MX2007002395A (pt)
WO (1) WO2007002722A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008536836A (ja) 2005-04-06 2008-09-11 シコール インコーポレイティド 抗がん剤の調製方法
CA2606945A1 (en) * 2005-06-27 2007-01-04 Sicor, Inc. An impurity of anastrozole intermediate, and uses thereof
EP2343278A1 (en) 2010-01-07 2011-07-13 Hexal AG A process for preparing trisubstituted phenyl derivatives comprising a (1H-1,2,4-triazol-1-yl)alkyl group
CN103342663B (zh) * 2013-07-15 2015-07-29 凯莱英医药集团（天津）股份有限公司 一种阿那曲唑关键中间体的制备方法
CN103524438B (zh) * 2013-10-31 2015-07-15 哈药集团制药总厂 一种阿那曲唑异构体的制备方法
CN103554041B (zh) * 2013-11-12 2016-02-03 江苏正大清江制药有限公司 一种制备阿那曲唑的合成工艺
CN108610297B (zh) * 2018-04-13 2020-12-29 梯尔希（南京）药物研发有限公司 一种阿那曲唑衍生物的制备方法
CN108997236B (zh) * 2018-07-31 2021-09-14 重庆华邦制药有限公司 一种阿那曲唑杂质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
FR2844125B1 (fr) * 2002-09-03 2004-12-17 Inventel Systemes Base centrale pour reseau local de radiocommunication prive et dispositif de radiocommunication incluant une telle base.
DE102005037484A1 (de) * 2004-08-09 2006-02-23 Chemagis Ltd. Neue Verfahren zur Herstellung von im Wesentlichen reinem Anastrozol
US20060189670A1 (en) * 2005-02-22 2006-08-24 Glenmark Pharmaceuticals Limited Process for the preparation of anastrozole and intermediates thereof
EP1705168A1 (en) * 2005-03-21 2006-09-27 Helm AG Improved process for side-chain bromination of alkyl-benzenes
US20080207915A1 (en) * 2005-10-05 2008-08-28 Radhakrishnan Tarur Venkatasub Process for the Preparation of 2,2'-[5-(1H-1,2,4-Triazole-1-Ylmethyl) -1,3-Phenylene] Di (2-Methylpropionitrile)
US20070100148A1 (en) * 2005-10-31 2007-05-03 Veerender Murki Process for preparing anastrozole
EP2024343B1 (en) * 2006-05-19 2015-09-09 Synthon B.V. Process for purification of anastrozole
WO2008034644A2 (en) * 2006-09-22 2008-03-27 Synthon B.V. Process for making anastrozole
US20080177081A1 (en) * 2007-01-19 2008-07-24 Formosa Laboratories, Inc. Process for Preparation of Anastrozole

Also Published As

Publication number Publication date
CA2606958A1 (en) 2007-01-04
JP2008511684A (ja) 2008-04-17
WO2007002722A2 (en) 2007-01-04
WO2007002722A3 (en) 2007-03-01
KR20080015436A (ko) 2008-02-19
US20080145946A1 (en) 2008-06-19
JP2008510020A (ja) 2008-04-03
US20070087441A1 (en) 2007-04-19
MX2007002395A (es) 2009-02-12
EP1896429A2 (en) 2008-03-12
BRPI0611116A2 (pt) 2010-08-10
CN101208312A (zh) 2008-06-25
KR20080015438A (ko) 2008-02-19
CN101233100A (zh) 2008-07-30

Similar Documents

Publication Publication Date Title
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
WO2006122186A3 (en) 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
PT1902037E (pt) 2,4-diamino-pirimidinas como inibidores de aurora
MA29870B1 (fr) Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs
ATE393764T1 (de) Polymorphe formen von valsartan
TW200732335A (en) Organic compounds
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
UA97806C2 (ru) Бензиламины, способ их получения и их применения в качестве противовоспалительных средств
BRPI0417992A (pt) método para purificar fsh
ATE420167T1 (de) Reinigungsverfahren für plasmid-dna
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
BRPI0607792A2 (pt) processo para a preparação de moduladores de opióides
BRPI0605902A (pt) processo de purificação para intermediário de anastrozol
TW200732337A (en) Organic compounds
BRPI0606170A2 (pt) purificação diastereomérica de rosuvastatina
BRPI0508969A (pt) compostos orgánicos
BR0115991A (pt) Processo para o isolamento e a purificação de epotilonas
WO2005012271A3 (en) Process for the synthesis of biaryl oxazolidinones
BRPI0519710A2 (pt) aminoÁlcoois tricÍclicos, processo para sua preparaÇço e seu emprego como anti-inflamatàrio
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
ATE496914T1 (de) Verfahren zur synthese von triazolen
BRPI0508430A (pt) processo para a preparação de inibidores da triptase

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.